Background : Mac-2 binding protein (Mac-2BP) is a secreted glycoprotein from the culture fluid of several human cancer cells, especially breast, lung, and gastric cells. Mac-2BP plays a role in immune response and cell adhesion activity in patients with various cancer and infectious diseases. In this study, we attempted to identify the regulators of Mac-2BP expression at the transcriptional level.
Methods : To determine the effect of epidermal growth factor (EGF) to Mac-2BP expression in gastric cancers, we constructed the different lengths of Mac-2BP promoter plasmids and measured the promoter activity and Mac-2BP expression. In addition to investigating the role of signal transducer and activator of transcription3 (STAT3) or human telomerase reverse transcriptase (hTERT) as a regulator of Mac-2BP, we transfected the small interfering RNA (siRNA) specific for STAT3 or hTERT, and Mac-2BP level was observed by a quantitative ELISA.
Results : EGF treatment could suppress the Mac-2BP transcription in HEK293 or gastric cancer cell lines (SNU-638 or AGS). In 5′ -deleted promoter experiment, pGL3-Mac Pro-2377 transfected cells showed a decreased luciferase activity compared to pGL3-Mac Pro-2277. We also identified thatSTAT3 Suppresses the Mac-2BP Expression 231 until they are activated by extracellular signaling proteins, such as mainly cytokines and growth factors and some peptides. These extracellular-signaling proteins can activate various tyrosine kinases, including Src and Jak family kinases that phosphorylate STAT proteins and thereby acquire high affinity DNA-binding activity [1, 2] . Then STAT dimerizes via reciprocal phosphotyrosine-SH2 domain interactions. Within minutes, the dimers translocate to the nucleus where they interact with other transcriptional modulators bound to cytokine inducible promoter regions of genes containing gamma activated site (GAS) motif and induce gene expression, and the duration and degree of gene activation are under strict regulation by a series of negatively acting proteins [1] [2] [3] . However, tyrosine phosphorylation is required for STAT3 to bind to specific DNA target sites, and nuclear import takes place constitutively and independently of tyrosine phosphorylation [3] .
In a number of tumor-derived cell lines, the STATs, particularly STAT3, are required to maintain transformed phenotypes. STAT5 is also commonly found to be consistently activated in certain malignancies, especially leukemias and lymphomas [4] . Cellular transformation by activated STAT3 and its relatives undoubtedly occurs through the transcriptional regulation of specific genes. Many STAT3 target genes are known, including those encoding the antiapoptotic proteins Bcl-xL, Mcl-1, and Bcl-2, the proliferation-associated proteins cyclin D1/D2 and c-Myc, and the pro-angiogenic factor vascular endothelial growth factor (VEGF) [5] [6] [7] [8] [9] [10] .
Since VEGF antigen in gastric cancer cells can serve as a pertinent predictive factor for hematogenous invasion or metastasis, it means that STAT3 activation is an important factor in gastric cancer oncogenesis. Indeed, constitutive activation of STAT3 signaling conferred resistance to apoptosis in human U266 myeloma cells, while inhibition of STAT3 signaling led to apoptosis of leukemic large granular lymphocytes and decreased Mcl-2 expression [6] . Therefore, still other genes must be regulated directly or indirectly by STAT3, many of which may contribute to oncogenesis or tumor progression [11, 12] .
Mac-2 binding protein (Mac-2BP) is a tumor-associated protein which has possible immuno-regulatory properties in CG-5 human breast cancer cells, and it is detected in the sera of normal as well as tumor-bearing patients [13] [14] [15] .
The Mac-2BP belongs to the scavenger receptor cysteinerich domain superfamily of proteins implicated in immune defense and immunoregulation [16] . Recently, we reported that the expression of Mac-2BP was up-regulated by human telomerase reverse transcriptase (hTERT) in gastric tumors, suggesting that Mac-2BP may be used as a diagnostic and/ or prognostic marker for gastric tumor patients [15] . For several years, we have focused on the function of Mac-2BP in gastric tumorigenesis in various viewpoints. In the current study, we show that epidermal growth factor (EGF) signal induces the STAT3 protein and it has a role for down-regulated the Mac-2BP expression at transcriptional level using by a luciferase reporter assay or knock-down experiments.
Therefore, it suggests that STAT3 is crucial as a negative regulator contrast to hTERT on Mac-2BP expression. 
MATERIALS AND METHODS

Cell culture and reagents
Western blot analysis
The proteins were separated via gel electrophoresis with 
Introduction of siRNA for specific STAT3 or hTERT
The unmodified 21-nucleotide synthetic RNAs were chemically synthesized (Samchully Pharm, Seoul, Korea).
The siRNA sequences were as followed: STAT3-siRNA sense, 5′ -CUU CAG ACC CGU CAA ATT-3′ ; antisense, 5′ -UUU GUU GAC GGG UCU GAA GTT-3′ ; hTERT-siRNA sense, 5′ -GAA CGU UCC GCA GAG AAA ATT-3′ ; antisense, 5′ -UUU UCU CUG CGG AAC GUU CTT-3′ ; siRNAcontrol (GL2) sense, 5′ -CGU ACG CGG AAU ACU UCG ATT-3′ ; antisense, 5′ -UCG AAG UAU UCC GCG UAC GTT-3′ . The transient transfection of synthetic siRNA was accomplished using Lipofectamine Plus Reagent (Invitrogen Corp, Carlsbad, CA, USA).
Mac-2BP reporter plasmid construction
The -2,377 bp DNA fragment (nucleotide positions -2,377 to +61) including the 5′flanking region was cloned by PCR using human genomic DNA as a template. The spe- 
Statistical analysis
Student' s t test was used to assess differences between groups. A P value <0.05 was considered significant. The values in the graphs correspond to the mean of at least three samples. Error bars indicate SD.
RESULTS
EGF treatment decreases the Mac-2BP expression
As shown in (Fig. 1) , 50% of Mac-2BP was decreased by EGF treatment, but it didn' t show dose dependent effects.
EGF treatment suppresses the Mac-2BP expression transcriptional level
hTERT and pGL3-MacPro-2,377 plasmid co-transfected into HEK293 cells showed that the activity was 25-fold increased in comparison with the control cells. However, the activity was adversely suppressed by EGF treatment ( Fig. 2A) .
Next, it was performed with gastric cancer cell lines, SNU-638 or AGS. As shown in (Fig. 2B, C) , EGF signal also suppressed the transcriptional activity of Mac-2BP promoter in gastric cancer cells.
Comparative analysis of transcriptional activities using 5 ′deletion mutants of Mac-2BP promoter
To further investigate the regulatory region of Mac-2BP promoter, a series of deleted mutants of the 5′ region were transiently transfected into SNU-638 or AGS cells (Fig. 3) . It revealed that the regulatory mechanisms of 
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transduction pathways, such as Ras/Raf/mitogen-activated protein kinase and PI3-kinase/Akt, which involve in cell proliferation, angiogenesis, and apoptosis [29] .
Although EGFR appears to be amplified and activated in many cancers, its role in the malignant phenotype is not entirely clear [30] . Several studies showed that in most cells EGF is growth stimulatory and anti-apoptotic; however, a number of tumor cell lines have been shown to be killed by this peptide through unknown mechanisms [31] [32] [33] . Consistent with these studies, our results showed that EGF has a negative role to regulate the Mac-2BP expression, although it couldn' t detect the apoptotic process.
In this study, we couldn' t detect the tyrosin-phosphorylated STAT3 (data not shown) even though STAT3 was strongly induced by EGF signal (Fig. 4) . 
